References

MicroRNA-21 is induced by rapamycin in a model of tuberous sclerosis (TSC) and lymphangioleiomyomatosis (LAM).
Trindade AJ, Medvetz DA, Neuman NA, Myachina F, Yu J, Priolo C, Henske EP.
PLoS One. 2013;8(3):e60014.
Lymphangioleiomyomatosis screening in women with tuberous sclerosis.
Cudzilo CJ, Szczesniak RD, Brody AS, Rattan MS, Krueger DA, Bissler JJ, Franz DN, McCormack FX, Young LR.
Chest. 2013 Aug;144(2):578-85.
Faslodex inhibits estradiol-induced extracellular matrix dynamics and lung metastasis in a model of lymphangioleiomyomatosis.
Li C, Zhou X, Sun Y, Zhang E, Mancini JD, Parkhitko A, Morrison TA, Silverman EK, Henske EP, Yu JJ.
Am J Respir Cell Mol Biol. 2013 Jul;49(1):135-42.
Perivascular epithelioid cell tumor located retroperitoneally with pulmonary lymphangioleiomyomatosis: report of a case.
Pata G, Tironi A, Solaini L, Tiziano T, Ragni F.
Surg Today. 2013 Mar 21. [Epub ahead of print]
Exonic mutations of TSC2/TSC1 are common but not seen in all sporadic pulmonary lymphangioleiomyomatosis.
Badri KR, Gao L, Hyjek E, Schuger N, Schuger L, Qin W, Chekaluk Y, Kwiatkowski DJ, Zhe X.
Am J Respir Crit Care Med. 2013 Mar 15;187(6):663-5.
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial.
Bissler JJ, Kingswood JC, Radzikowska E, Zonnenberg BA, Frost M, Belousova E, Sauter M, Nonomura N, Brakemeier S, de Vries PJ, Whittemore VH, Chen D, Sahmoud T, Shah G, Lincy J, Lebwohl D, Budde K.
Lancet. 2013 Mar 9;381(9869):817-24
Targeted approaches toward understanding and treating pulmonary lymphangioleiomyomatosis (LAM).
Hammes SR, Krymskaya VP.
Horm Cancer. 2013 Apr;4(2):70-7.
The role of vascular endothelial growth factor-D in diagnosis of lymphangioleiomyomatosis (LAM).
Xu KF, Zhang P, Tian X, Ma A, Li X, Zhou J, Zeng N, Gui YS, Guo Z, Feng R, Zhang W, Sun W, Cai B.
Respir Med. 2013 Feb;107(2):263-8.
Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registry.
Oprescu N, McCormack FX, Byrnes S, Kinder BW.
Lung. 2013 Feb;191(1):35-42.
Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasm.
McCormack FX, Travis WD, Colby TV, Henske EP, Moss J.
Am J Respir Crit Care Med. 2012 Dec 15;186(12):1210-2.
Utility of transbronchial biopsy in the diagnosis of lymphangioleiomyomatosis.
Meraj R, Wikenheiser-Brokamp KA, Young LR, Byrnes S, McCormack FX.
Front Med. 2012 Dec;6(4):395-405.
Lymphangioleiomyomatosis - a wolf in sheep's clothing.
Henske EP, McCormack FX.
J Clin Invest. 2012 Nov 1;122(11):3807-16.